Alterity Therapeutics Ltd
ATH•Health Care•Biotechnology•Last updated: Dec 25
About
Alterity Therapeutics Ltd is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company is primarily engaged in the research and development of treatments for conditions such as Alzheimer's and Parkinson's diseases. Alterity's lead product candidate is designed to target the underlying causes of neurodegeneration by restoring neuronal health.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- ATH
Related Shares
Investor Resources
Should you buy Alterity Therapeutics Ltd right now?
While ATH looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now